7Fisher ER,Wang J,Bryant J,et al.Pathobiology of preoperative chemotherapy:findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-18.Cancer,2002,95:681-695. 被引量：1
9Wolff AC,Hammond ME,Schwartz JN,et al.American Society of Clinical Ontology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2testing in breast cancer.J Clin Oncol,2007,25:118-145. 被引量：1
10Taucher S,Rudas M,Gnant M,et al.Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy.Endoer Relat Cancer,2003,10:91-98. 被引量：1
7Van der Hage JA,Van de Velde CJ,Julien JP,et al.Preoperative chemotherapy in primary operable breast cancer:results from the European Organization for Research and Treatment of Cancer trial10902[J].J Clin Oncol,2001,19(22):4224-4237. 被引量：1
8Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer[J].N Engl J Med,2002,347(16):1233-1241. 被引量：1
9Bluemke DA,Gatsonis CA,Chen MH,et al.Magnetic resonance imaging of the breast prior to biopsy[J].JAMA,2004,292(22):2735-2742. 被引量：1
10Lyou CY,Cho N,Kim SM,et al.Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy[J].Korean J Radiol,2011,12(1):34-43. 被引量：1
